Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.02.25.707999

Closed-loop error damping in human BCI using pre-error motor cortex activity

Abstract

Intracortical brain-computer interfaces (BCIs) are used to decode motor intent from neural population activity; their main clinical application is to restore function for individuals with motor or communication deficits. However, when trying to reconstruct movement trajectories, such as in computer cursor control, even state-of-the-art decoders fall short of able-bodied performance during online BCI control. This calls for alternative approaches to improve the usability of motor BCIs. Here, we leveraged an error signal, i.e. a neural correlate of faulty motor control that can be detected from neural activity. By detecting this error signal in parallel to performing movement decoding, it is possible to perform error modulation, i.e. real-time error detection and correction during a closed-loop motor BCI task. We analyzed data from four individuals with upper limb impairment due to cervical spinal cord injury who each used an intracortical BCI to perform a continuous cursor control task with visual feedback. A classifier was trained to detect the error signal and was used to perform online error detection during BCI control to limit ongoing errors (defined as movement of the controller away from its target) without requiring any specific action from the participants. Our contribution is three-fold. First, we show that the error signal has a pre-error component. Cortical activity was already significantly modulated before the onset of the kinematically-defined error, theoretically allowing for earlier detection. Second, we show that error modulation significantly improves performance during online BCI control of cursor kinematics. Finally, we show that the error signal can be robustly leveraged across contexts, as error modulation improves performance in more complex motor tasks (involving for instance grasp and drag actions) or other environments without task-specific calibration. Overall, our results suggest that the error signal can be robustly disentangled from motor intent in cortical activity, and that even a simple linear classifier can enable error modulation in parallel to a continuous kinematic decoder, yielding more reliable and accurate BCI control.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gontier, C., Hockeimer, W., Kunigk, N. G., Canario, E., Endsley, L. J., Downey, J. E., Weiss, J. M., Dekleva, B., Collinger, J. L.. 2026-02-26. Closed-loop error damping in human BCI using pre-error motor cortex activity. https://doi.org/10.64898/2026.02.25.707999

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗